ERK and the F-box protein betaTRCP target STAT1 for degradation.

The transcription factor STAT1 has roles in development, homeostasis, cellular differentiation, and apoptosis and has been postulated to function as a tumor suppressor. STAT1 is activated by tyrosine or serine phosphorylation in response to specific cytokines or following a variety of stress-induced stimuli. STAT1 activity is carefully regulated to prevent ...
sustained STAT1-mediated transcription, although the molecular mechanisms involved in the modulation of STAT1 stability are poorly understood. Here we show that activated STAT1 is degraded at the proteasome by a mechanism involving the F-box E3 ligase, SCF(betaTRCP). Active p42/p44 MAPK-ERK phosphorylates STAT1 on serine 727 and targets it for proteasomal degradation. SCF(betaTRCP) binds wild-type STAT1 but not the nonphosphorylatable mutant STAT1(S727A). Moreover, silencing betaTRCP expression or pharmacological inhibition of ERK activity stabilized STAT1 expression. These data suggest that constitutively active ERK may inappropriately degrade STAT1, with loss of its pro-apoptotic and tumor suppressor functions.
Mesh Terms:
Animals, Apoptosis, Cell Differentiation, Cell Line, Cytokines, Homeostasis, Mice, Mitogen-Activated Protein Kinase 1, Phosphorylation, Proteasome Endopeptidase Complex, STAT1 Transcription Factor, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, beta-Transducin Repeat-Containing Proteins
J. Biol. Chem.
Date: Jun. 06, 2008
Download Curated Data For This Publication
120333
Switch View:
  • Interactions 5
  • PTM Genes 1